The Biomedical Research Institute (BIOMED) of Hasselt University conducts high level multidisciplinary research to advance progress in human life sciences. High-end technology is used to deliver novel insights in three main disease areas: (neuro)immunology, neuroscience and cardiovascular disease. BIOMED aims to translate new scientific discoveries into applications that contribute to a healthy society
As the lead partner of Healthy Aging, BIOMED has extensive expertise at the level of immune regulation and biomarker research, development of immune interventions and mechanisms of immune aging in the context of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). BIOMED builds on an elaborate regional network of neurologists and rheumatologists to collect well characterized patient samples in the Universitary Biobank Limburg (UbiLim). Its dedicated lab facilities and its critical mass of professors, PhDs and post docs working on immunology are the ideal setting to successfully develop new biomarkers for healthy and pathological aging.
BIOMEDs spearhead research activities are organized in accordance with the bench to bedside concept. BIOMED thus aims at valorizing newly created knowledge. A spin-off was setup (Apitope) and a license agreement was signed (Innova Diagnostics) in frame of further valorisation of RA and MS biomarkers generated at BIOMED. BIOMED further actively collaborates in innovation projects and contract research for the life sciences industry to help bring candidate drugs to the market.
BIOMED participated in various previous interreg projects, namely Interreg EMR : Alma in Silico (partner), BioMiMedics (partner) , and Interreg Flanders-Netherlands: VariA (partner) and NanosensEU (lead partner) and therefore has good expertise with the management and organisation of European co-financing projects.